Drug intelligence / Profile preview

lidocaine + nifedipine

Development stage
Unknown
Lead developer
Laboratoires Leurquin Mediolanum
Modality
Small Molecules
Administration
Topical, Rectal
01

Overview

Lidocaine + nifedipine is a fixed-dose combination drug, most commonly formulated as a topical ointment or cream, used primarily for the treatment of chronic anal fissures and related anorectal pain. Lidocaine is an amide-type local anesthetic that works by reversibly stabilizing neuronal membranes, thereby blocking the initiation and conduction of nerve impulses to provide local anesthesia. Nifedipine is a dihydropyridine calcium channel blocker that relaxes smooth muscle cells in blood vessels and the internal anal sphincter by inhibiting voltage-dependent calcium channels. This dual action results in rapid pain relief (from lidocaine) and reduced sphincter spasm with improved blood flow (from nifedipine), promoting healing of fissures. The combination has demonstrated high efficacy in clinical trials for healing chronic anal fissure, reducing resting anal pressure, relieving pain after hemorrhoidectomy, and improving patient comfort[1][4][5][6][7][8].

Brand names
NIFEDULES LDCAnoblissAnoreliefNifecaineFidonalAnosureAnofresh NLFisofineNifedipXylocaine NFLoxheal
Other names
lidocaine and nifedipine ointment
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on lidocaine + nifedipine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + nifedipine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call